Premium
Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV‐related hepatocellular carcinoma
Author(s) -
Wu Cheng,
Wang Zhanfeng,
Liu Lijie,
Zhao Peng,
Wang Wenjing,
Yao Dingkang,
Shi Bing,
Lu Junhua,
Liao Ping,
Yang Yaning,
Zhu Liang
Publication year - 2009
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2008.05580.x
Subject(s) - hepatocellular carcinoma , medicine , cirrhosis , surface enhanced laser desorption/ionization , predictive value , mass spectrometry , pathology , tandem mass spectrometry , chemistry , chromatography , protein mass spectrometry
Background and Aim: To screen for serum biomarkers of HBV‐related hepatocellular carcinoma (HCC) and HBV‐related liver cirrhosis (LC) in an attempt to seek a new method for differential diagnosis of HCC and LC using surface‐enhanced laser desorption/ionization time‐of‐flight mass spectrometry (SELDI‐TOF‐MS) techniques. Methods: Using SELDI‐TOF‐MS, serum proteins/peptide profiles on the immobilized metal ion affinity capture (IMAC) protein chips were obtained from 29 HCC patients and 30 LC patients. Discriminant analysis was carried out to establish new diagnostic methods using protein/peptide peaks with or without α‐fetoprotein (AFP). Results: Forty‐five protein/peptide peaks changed much more in the HCC group than they did in the LC group. Discriminant analysis using the Wilcoxon rank‐sum test showed high sensitivity and specificity in distinguishing HCC from LC. The most significantly differentiating peak, 3892, offered 69.0% sensitivity, 83.3% specificity and 80% positive predictive value in distinguishing HCC and LC. Interestingly, six HCC patients with negative serum AFP were confirmed by peak 3892. The combination of multi‐protein peaks (m/z = 9297, 29 941) with AFP offered an 82.8% sensitivity, 93.3% specificity and 92.3% positive predictive value, which was much better than AFP alone ( P = 0.013). Conclusions: Special proteins/peptides of serum may differentiate HBV‐related HCC and HBV‐related LC, indicating that SELDI‐TOF‐MS may be useful to distinguish HCC from LC with the proper discriminant analytical method. SELDI peak 3892 may be a complementary diagnostic marker to positive AFP for HCC and a potential marker for the diagnosis of AFP‐negative HCC as well.